During our observation period of up to 34 months, cNfL and sNfL levels in children with SMA and 2 SMN2 copies decrease while those in children with SMA and >2 SMN2 copies only marginally decrease during the course of treatment. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.